In summary, in letrozole-induced PCOS rats, soy isoflavones may reduce the release of inflammatory cytokines by inhibiting the activation of NF-κB signaling pathway, thereby regulating serum hormone disorders and improving the morphology and function of polycystic ovaries. Here, NFKB1 is linked to polycystic ovary syndrome.